University virologist developing more potent vaccine technology with applicability to many viruses

Simple item page
dc.contributor.authorTrulove, Susanen
dc.coverage.spatialBlacksburg, Va.en
dc.date.accessioned2015-10-29T21:34:26Zen
dc.date.available2015-10-29T21:34:26Zen
dc.date.issued2009-05-06en
dc.description.abstractVirginia Tech virologist Chris Roberts' goal is to develop a platform for a flu vaccine that allows rapid modifications to meet new strains of flu.en
dc.format.mimetypetext/htmlen
dc.identifier.urihttp://hdl.handle.net/10919/62019en
dc.publisherVirginia Tech. University Relationsen
dc.rightsIn Copyrighten
dc.rights.holderVirginia Tech. University Relationsen
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subjectResearchen
dc.titleUniversity virologist developing more potent vaccine technology with applicability to many virusesen
dc.typePress releaseen
dc.type.dcmitypeTexten
Files
Original bundle
Now showing 1 - 1 of 1
Name:
2009-394.html
Size:
8.83 KB
Format:
Hypertext Markup Language
Download
Collections
Virginia Tech News